These values fall below the threshold for a reliable diagnostic assay, underscoring a fundamental trade-off: while complete loss of p16 can be highly specific for malignancy (particularly in distinguishing melanoma from common nevi, Spitz nevi, or deep penetrating lesions), retained expression cannot definitively exclude it. This evidence concerns the gene CDKN2A and melanoma.